CVS Health (CVS) Financials: Revenue & Earnings

CVS price $90.87 -0.26 -0.29%

Ticker
CVS
Price
$90.87
Change
-0.26 -0.29%
Market cap ?
$116.22B
P/E ?
24.16
Forward P/E ?
11.29
Dividend yield ?
2.87%
Beta ?
0.60
Sector
Healthcare
Industry
Medical - Healthcare Plans
Stocklytics score
47
Value
65
Quality
29
Growth
48

Stocklytics score rationale: value 65, quality 29, growth 48.

Financials

2016201720182019202020212022202320242025
177546000000184786000000194579000000256776000000268706000000292111000000322467000000357776000000372809000000402067000000

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in…

Fair value

CVS fair value $154.73. Price $90.87. Price is 41% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 80% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 11.76B. Growth 8.38%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.28B. Net debt 85.08B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare CVS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—1.66—104.72B
2026-08-052.581.85106.10B100.03B
2026-05-062.572.18100.43B94.99B
2026-02-101.091.00105.69B103.70B
2025-10-291.601.37102.87B98.81B
2025-07-311.811.4698.92B94.53B
2025-05-012.251.7094.59B93.68B
2025-02-121.190.9197.71B97.09B
2024-11-061.091.4495.43B92.75B
2024-08-071.831.7391.23B91.41B
2024-05-011.311.7088.44B89.33B
2024-02-072.122.0193.81B90.36B
2023-11-012.212.1389.76B88.25B
2023-08-022.212.1288.92B86.53B
2023-05-032.202.0785.28B80.81B
2023-02-081.991.9283.85B76.43B
2022-11-022.091.9981.16B76.74B
2022-08-032.402.1780.64B76.41B
2022-05-042.222.1576.83B75.54B
2022-02-091.981.9476.60B75.66B
2021-11-031.971.7973.79B70.34B
2021-08-042.422.0672.62B70.30B
2021-05-042.041.7269.10B68.34B
2021-02-161.301.2469.55B66.19B
2020-11-061.661.3467.06B50.42B
2020-08-052.641.9365.34B47.77B
2020-05-061.911.6366.75B56.97B
2020-02-121.731.6866.89B64.96B
2019-11-061.841.7764.81B62.34B
2019-08-071.891.6963.43B56.72B
2019-05-011.621.5061.65B57.08B
2019-02-202.142.0754.91B52.60B
2018-11-061.731.7147.49B46.94B
2018-08-081.691.6146.92B44.70B
2018-05-021.481.3945.74B43.58B
2018-02-081.921.8948.38B47.65B
2017-11-061.501.4846.18B45.87B
2017-08-081.331.3145.69B45.00B
2017-05-021.171.1044.51B41.85B
2017-02-091.711.6745.97B44.92B

Dividends

Yield 2.93%. Payout ratio 69.63%. Frequency Quarterly.

Safety score 89/100 · Safe. Payout ratio is 70% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 42 separate years. Yield is 2.9%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-10-22$0.672026-10-222026-11-02Quarterly
2026-07-23$0.672026-07-232026-08-03Quarterly
2026-04-23$0.672026-04-232026-05-04Quarterly
2026-01-22$0.672026-01-222026-02-02Quarterly
2025-10-23$0.672025-10-232025-11-03Quarterly
2025-07-22$0.672025-07-222025-08-01Quarterly
2025-04-22$0.672025-04-222025-05-01Quarterly
2025-01-23$0.672025-01-232025-02-03Quarterly
2024-10-21$0.672024-10-212024-11-01Quarterly
2024-07-22$0.672024-07-222024-08-01Quarterly
2024-04-19$0.672024-04-222024-05-01Quarterly
2024-01-19$0.672024-01-222024-02-01Quarterly
2023-10-19$0.602023-10-202023-11-01Quarterly
2023-07-20$0.602023-07-212023-08-01Quarterly
2023-04-20$0.602023-04-212023-05-01Quarterly
2023-01-19$0.602023-01-202023-02-01Quarterly
2022-10-20$0.552022-10-212022-11-01Quarterly
2022-07-21$0.552022-07-222022-08-01Quarterly
2022-04-21$0.552022-04-222022-05-02Quarterly
2022-01-20$0.552022-01-212022-02-01Quarterly
2021-10-21$0.502021-10-222021-11-01Quarterly
2021-07-22$0.502021-07-232021-08-02Quarterly
2021-04-22$0.502021-04-232021-05-03Quarterly
2021-01-21$0.502021-01-222021-02-01Quarterly
2020-10-21$0.502020-10-222020-11-02Quarterly
2020-07-22$0.502020-07-232020-08-03Quarterly
2020-04-22$0.502020-04-232020-05-04Quarterly
2020-01-22$0.502020-01-232020-02-03Quarterly
2019-10-23$0.502019-10-242019-11-04Quarterly
2019-07-24$0.502019-07-252019-08-02Quarterly
2019-04-22$0.502019-04-232019-05-03Quarterly
2019-01-24$0.502019-01-252019-02-04Quarterly
2018-10-23$0.502018-10-242018-11-01Quarterly
2018-07-24$0.502018-07-252018-08-01Quarterly
2018-04-20$0.502018-04-232018-05-03Quarterly
2018-01-23$0.502018-01-242018-02-02Quarterly
2017-10-23$0.502017-10-242017-11-03Quarterly
2017-07-20$0.502017-07-242017-08-03Quarterly
2017-04-19$0.502017-04-212017-05-01Quarterly
2017-01-20$0.502017-01-242017-02-02Quarterly
2016-10-20$0.422016-10-242016-11-03Quarterly
2016-07-19$0.422016-07-212016-08-01Quarterly
2016-04-20$0.422016-04-222016-05-02Quarterly
2016-01-20$0.422016-01-222016-02-02Quarterly
2015-10-20$0.352015-10-222015-11-02Quarterly
2015-07-21$0.352015-07-232015-08-03Quarterly
2015-04-22$0.352015-04-242015-05-04Quarterly
2015-01-20$0.352015-01-222015-02-02Quarterly
2014-10-21$0.282014-10-232014-11-03Quarterly
2014-07-17$0.282014-07-212014-08-01Quarterly
2014-04-17$0.282014-04-222014-05-02Quarterly
2014-01-21$0.282014-01-232014-02-03Quarterly
2013-10-17$0.232013-10-212013-11-01Quarterly
2013-07-18$0.232013-07-222013-08-02Quarterly
2013-04-19$0.232013-04-232013-05-03Quarterly
2013-01-22$0.232013-01-242013-02-04Quarterly
2012-10-18$0.162012-10-222012-11-02Quarterly
2012-07-19$0.162012-07-232012-08-03Quarterly
2012-04-19$0.162012-04-232012-05-03Quarterly
2012-01-19$0.162012-01-232012-02-02Quarterly
2011-10-19$0.122011-10-212011-11-01Quarterly
2011-07-20$0.122011-07-222011-08-02Quarterly
2011-04-19$0.122011-04-222011-05-03Quarterly
2011-01-19$0.122011-01-212011-02-02Quarterly
2010-10-20$0.092010-10-222010-11-02Quarterly
2010-07-20$0.092010-07-222010-08-02Quarterly
2010-04-21$0.092010-04-232010-05-04Quarterly
2010-01-20$0.092010-01-222010-02-02Quarterly
2009-10-20$0.082009-10-222009-11-03Quarterly
2009-07-21$0.082009-07-232009-08-03Quarterly
2009-04-20$0.082009-04-222009-05-04Quarterly
2009-01-21$0.082009-01-232009-02-03Quarterly
2008-10-17$0.072008-10-212008-11-03Quarterly
2008-07-17$0.072008-07-212008-08-01Quarterly
2008-04-17$0.062008-04-212008-05-02Quarterly
2008-01-17$0.062008-01-222008-02-01Quarterly
2007-10-18$0.062007-10-222007-11-02Quarterly
2007-07-19$0.062007-07-232007-08-03Quarterly
2007-04-20$0.062007-04-242007-05-04Quarterly
2007-01-18$0.052007-01-222007-02-02Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2026-06-26Clark James DavidSell454$90.9841.30K
2026-05-31Newman BrianSell2.48K$90.98225.45K
2026-05-31Compton-Phillips AmySell7.62K$90.98693.09K
2026-05-21AGUIRRE FERNANDOSell1.56K$93.50146.14K
2026-05-21ROBBINS LARRYSell370.46K$93.4534.62M
2026-05-21ROBBINS LARRYSell378.00K$58.2922.03M
2026-05-20AGUIRRE FERNANDOSell30.44K$93.782.85M
2026-05-20ROBBINS LARRYSell797.63K$93.4874.56M
2026-05-20ROBBINS LARRYSell152.69K$94.8114.48M
2026-05-20ROBBINS LARRYSell66.88K$95.676.40M
2026-05-20ROBBINS LARRYSell800$96.2877.03K
2026-05-19ROBBINS LARRYSell1.98M$94.45187.33M
2026-05-19ROBBINS LARRYSell151$95.1814.37K
2026-05-14Gallina John EBuy1.45K$97.15140.63K
2026-05-14Mahoney Michael FBuy1.74K$97.15168.75K
2026-05-14AGUIRRE FERNANDOBuy1.56K$97.15151.85K
2026-05-14Balser Jeffrey R.Buy2.06K$97.15199.93K
2026-05-14KIRBY J SCOTTBuy1.45K$97.15140.58K
2026-05-14Norwalk Leslie VBuy1.45K$97.15140.58K
2026-05-14SANSONE GUY PBuy1.45K$97.15140.58K
2026-05-14DECOUDREAUX ALECIA ABuy1.45K$97.15140.63K
2026-05-14Finucane Anne A.Buy1.54K$97.15150.00K
2026-05-14BROWN C DAVID IIBuy1.54K$97.15150.00K
2026-05-14Shulman Douglas H.Buy1.45K$97.15140.63K
2026-05-14ROBBINS LARRYBuy1.93K$97.15187.50K
2026-05-08Mandadi TilakSell69.55K$89.586.23M
2026-04-01Shah Prem SSell1.48K$72.49107.58K
2026-04-01Nelson Steven HSell2.43K$72.49176.30K
2026-04-01Mandadi TilakSell3.63K$72.49263.43K
2026-04-01Khichi Samrat S.Sell3.54K$72.49256.69K
2026-04-01Joyner J. DavidSell8.03K$72.49582.02K
2026-04-01Clark James DavidSell3.26K$72.49236.46K
2026-04-01CAPOZZI HEIDI BSell1.33K$72.4996.70K
2026-03-31Shah Prem SBuy161.68K$71.8211.61M
2026-03-31Shah Prem SBuy25.06K$71.821.80M
2026-03-31Newman BrianBuy125.75K$71.829.03M
2026-03-31Newman BrianBuy19.49K$71.821.40M
2026-03-31Nelson Steven HBuy143.71K$71.8210.32M
2026-03-31Nelson Steven HBuy22.28K$71.821.60M
2026-03-31Mandadi TilakBuy143.71K$71.8210.32M
2026-03-31Mandadi TilakBuy22.28K$71.821.60M
2026-03-31Khichi Samrat S.Buy80.84K$71.825.81M
2026-03-31Khichi Samrat S.Buy12.53K$71.82899.98K
2026-03-31Joyner J. DavidBuy86.33K$71.826.20M
2026-03-31Compton-Phillips AmyBuy5.57K$71.82399.97K
2026-03-31Compton-Phillips AmyBuy35.93K$71.822.58M
2026-03-31Clark James DavidBuy11.14K$71.82799.93K
2026-03-31Clark James DavidBuy11.98K$71.82860.12K
2026-03-31CAPOZZI HEIDI BBuy10.03K$71.82720.00K
2026-03-31CAPOZZI HEIDI BBuy64.67K$71.824.64M
2026-03-19Gallina John EBuy582$71.8641.82K
2026-03-19Gallina John EOther0——
2026-02-28Khichi Samrat S.Sell7.89K$79.60627.73K
2026-02-28Joyner J. DavidSell1.94K$79.90155.33K
2026-01-01Shah Prem SSell247$80.1319.79K
2025-12-01Clark James DavidSell220$79.1017.40K
2025-11-30Mandadi TilakSell6.58K$80.36528.37K
2025-11-30FARAH ROGER NSell9.75K$80.36783.35K
2025-11-30CAPOZZI HEIDI BSell9.47K$80.36761.01K
2025-11-20Shulman Douglas H.Buy1.65K$76.04125.62K
2025-11-20SANSONE GUY PBuy1.65K$76.04125.62K
2025-11-20ROBBINS LARRYBuy2.20K$76.04167.50K
2025-11-20Norwalk Leslie VBuy1.65K$76.04125.62K
2025-11-20Mahoney Michael FBuy2.02K$76.04153.75K
2025-11-20KIRBY J SCOTTBuy1.65K$76.04125.62K
2025-11-20Finucane Anne A.Buy1.78K——
2025-11-20Finucane Anne A.Buy591$76.0444.94K
2025-11-20DECOUDREAUX ALECIA ABuy1.65K——
2025-11-20BROWN C DAVID IIBuy1.77K$76.04134.97K
2025-11-20Balser Jeffrey R.Buy1.77K$76.04134.97K
2025-11-20AGUIRRE FERNANDOBuy1.80K$76.04136.87K
2025-08-31Shah Prem SSell7.00K$73.15511.68K
2025-08-31Mandadi TilakSell12.83K$73.15938.81K
2025-08-20Finucane Anne A.Sell7.50K$71.02532.65K
2025-06-05SANSONE GUY PBuy1.57K$63.70100.01K
2025-05-31Newman BrianBuy94.79K$64.046.07M
2025-05-31Newman BrianBuy21.86K$64.041.40M
2025-05-31Compton-Phillips AmyBuy6.25K$64.04399.99K
2025-05-31Compton-Phillips AmyBuy46.84K$64.043.00M
2025-05-31Compton-Phillips AmyBuy27.08K$64.041.73M
2025-05-19Compton-Phillips AmyOther0——
2025-05-19Compton-Phillips AmyOther0——
2025-05-15Shulman Douglas H.Buy2.08K$60.47125.60K
2025-05-15SANSONE GUY PBuy2.08K$60.47125.60K
2025-05-15ROBBINS LARRYBuy2.77K——
2025-05-15Norwalk Leslie VBuy2.08K$60.47125.60K
2025-05-15Mahoney Michael FBuy144$60.478.71K
2025-05-15Mahoney Michael FBuy2.54K——
2025-05-15KIRBY J SCOTTBuy2.77K$60.47167.44K
2025-05-15Finucane Anne A.Buy2.08K——
2025-05-15Finucane Anne A.Buy692$60.4741.85K
2025-05-15DECOUDREAUX ALECIA ABuy2.08K——
2025-05-15BROWN C DAVID IIBuy2.23K$60.47134.97K
2025-05-15Balser Jeffrey R.Buy2.23K$60.47134.97K
2025-05-15AGUIRRE FERNANDOBuy2.26K$60.47136.84K
2025-05-12Newman BrianOther0——
2025-05-12Newman BrianOther0——
2025-05-12Newman BrianOther0——
2025-05-06ROBBINS LARRYSell150.00K$66.6710.00M
2025-05-05ROBBINS LARRYSell1.23M$67.3782.65M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 2.17K, holders +204 vs prior quarter. Ownership 90.25%.

HolderSharesChangeChange %Value
BLACKROCK, INC.123.22M-2.70M-2.14%12.75B
VANGUARD CAPITAL MANAGEMENT LLC83.32M665.29K+0.80%8.62B
CAPITAL WORLD INVESTORS74.95M-2.30M-2.97%7.75B
STATE STREET CORP60.28M961.23K+1.62%6.24B
DODGE & COX50.01M-1.77M-3.41%5.17B
WELLINGTON MANAGEMENT GROUP LLP33.80M11.23M+49.78%3.50B
GEODE CAPITAL MANAGEMENT, LLC29.90M440.61K+1.50%3.08B
FMR LLC28.92M-2.28M-7.30%2.99B
VANGUARD PORTFOLIO MANAGEMENT LLC26.64M639.91K+2.46%2.76B
CAPITAL RESEARCH GLOBAL INVESTORS24.33M4.32M+21.57%2.52B
PRICE T ROWE ASSOCIATES INC /MD/24.20M420.74K+1.77%2.50B
BANK OF AMERICA CORP /DE/23.19M13.84M+147.95%2.40B
JPMORGAN CHASE & CO22.11M-7.41M-25.11%2.29B
INVESCO LTD.20.60M-4.54M-18.07%2.13B
MORGAN STANLEY18.61M780.91K+4.38%1.92B
NORGES BANK18.04M18.04MNew1.87B
CAPITAL INTERNATIONAL INVESTORS15.39M-4.62K-0.03%1.59B
GOLDMAN SACHS GROUP INC13.41M11.79M+728.20%1.39B
CHARLES SCHWAB INVESTMENT MANAGEMENT INC13.26M-415.61K-3.04%1.37B
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.13.26M13.26MNew1.37B
DAVIS SELECTED ADVISERS11.87M-373.75K-3.05%1.23B
PZENA INVESTMENT MANAGEMENT LLC11.77M-2.00M-14.55%1.22B
NORTHERN TRUST CORP11.47M-169.72K-1.46%1.19B
FRANKLIN TEMPLETON INC9.99M3.74M+59.98%1.03B
LEGAL & GENERAL GROUP PLC9.17M-342.72K-3.60%948.95M

Earnings and financials

CVS Health Corp. (CVS) trades at $90.87, with a market cap of $116.22B and a trailing P/E of 24.16. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
177546000000184786000000194579000000256776000000268706000000292111000000322467000000357776000000372809000000402067000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CVS Health (CVS) Financials: Revenue & Earnings

CVS$90.87-0.26 -0.29%

$116.22B

Market Cap

24.16

P/E

11.29

Forward P/E

47

Score

Price History